The University of Southampton
University of Southampton Institutional Repository

Salbutamol but not ipratropium abolishes leukotriene D(4)-induced gas exchange abnormalities in asthma

Salbutamol but not ipratropium abolishes leukotriene D(4)-induced gas exchange abnormalities in asthma
Salbutamol but not ipratropium abolishes leukotriene D(4)-induced gas exchange abnormalities in asthma
Purpose: leukotriene D(4) (LTD(4)) is a central mediator in asthma inducing bronchoconstriction and profound disturbances in pulmonary gas exchange in asthmatic subjects. The aim of the study was to compare, for the first time, the influence of the bronchodilators salbutamol (400 ?g) and ipratropium (80 ?g) on lung function changes induced by inhaled LTD(4).

Methods: treatments were evaluated in a randomized, three-period, double-blind, placebo-controlled, cross-over study where spirometric and pulmonary gas exchange indices were followed in 12 subjects with mild asthma before and after LTD(4) challenge.

Results: compared with placebo, salbutamol provided significant protection against the fall in FEV(1) (forced expiratory volume in 1 s) after LTD(4) challenge. Salbutamol also abolished the LTD(4)-induced gas exchange disturbances [decreased arterial oxygen tension (PaO(2)) and increased alveolar-arterial oxygen tension difference (AaPO(2))]. Ipratropium provided significant but less marked attenuation of the changes in FEV(1) and arterial oxygenation induced by LTD(4).

Conclusions: despite the equal bronchodilatory effects of salbutamol and ipratropium before the challenge with LTD(4), salbutamol was superior to ipratropium in preventing spirometric and gas exchange abnormalities. This result indicates a broader action of salbutamol on several of the disturbances that contribute to airway obstruction including, for example, exudation of plasma in the airway mucosa. The clinical implication of this new finding is that in this model of acute asthmatic airway obstruction, salbutamol was more effective than ipratropium
0031-6970
Dahlén, Barbro
9a1ebc34-9a8e-46a3-9933-fda2cbdd4ab9
Gómez, Federico P.
3e8a6caa-e019-4873-b3da-40faeb0e2426
Casas, Alejandro
9b8d45d4-0ac1-4534-ba07-4d8aabc7e0da
Howarth, Peter H.
ff19c8c4-86b0-4a88-8f76-b3d87f142a21
Dahlén, Sven-Erik
9e18ae23-c6a1-413c-93fe-203949a4dcda
Rodriguez-Roisin, Robert
9682798b-db0f-4ac2-9a0b-a34e79439f92
Dahlén, Barbro
9a1ebc34-9a8e-46a3-9933-fda2cbdd4ab9
Gómez, Federico P.
3e8a6caa-e019-4873-b3da-40faeb0e2426
Casas, Alejandro
9b8d45d4-0ac1-4534-ba07-4d8aabc7e0da
Howarth, Peter H.
ff19c8c4-86b0-4a88-8f76-b3d87f142a21
Dahlén, Sven-Erik
9e18ae23-c6a1-413c-93fe-203949a4dcda
Rodriguez-Roisin, Robert
9682798b-db0f-4ac2-9a0b-a34e79439f92

Dahlén, Barbro, Gómez, Federico P., Casas, Alejandro, Howarth, Peter H., Dahlén, Sven-Erik and Rodriguez-Roisin, Robert (2012) Salbutamol but not ipratropium abolishes leukotriene D(4)-induced gas exchange abnormalities in asthma. European Journal of Clinical Pharmacology. (doi:10.1007/s00228-012-1256-z). (PMID:22457014)

Record type: Article

Abstract

Purpose: leukotriene D(4) (LTD(4)) is a central mediator in asthma inducing bronchoconstriction and profound disturbances in pulmonary gas exchange in asthmatic subjects. The aim of the study was to compare, for the first time, the influence of the bronchodilators salbutamol (400 ?g) and ipratropium (80 ?g) on lung function changes induced by inhaled LTD(4).

Methods: treatments were evaluated in a randomized, three-period, double-blind, placebo-controlled, cross-over study where spirometric and pulmonary gas exchange indices were followed in 12 subjects with mild asthma before and after LTD(4) challenge.

Results: compared with placebo, salbutamol provided significant protection against the fall in FEV(1) (forced expiratory volume in 1 s) after LTD(4) challenge. Salbutamol also abolished the LTD(4)-induced gas exchange disturbances [decreased arterial oxygen tension (PaO(2)) and increased alveolar-arterial oxygen tension difference (AaPO(2))]. Ipratropium provided significant but less marked attenuation of the changes in FEV(1) and arterial oxygenation induced by LTD(4).

Conclusions: despite the equal bronchodilatory effects of salbutamol and ipratropium before the challenge with LTD(4), salbutamol was superior to ipratropium in preventing spirometric and gas exchange abnormalities. This result indicates a broader action of salbutamol on several of the disturbances that contribute to airway obstruction including, for example, exudation of plasma in the airway mucosa. The clinical implication of this new finding is that in this model of acute asthmatic airway obstruction, salbutamol was more effective than ipratropium

This record has no associated files available for download.

More information

e-pub ahead of print date: 29 March 2012
Organisations: Clinical & Experimental Sciences

Identifiers

Local EPrints ID: 337432
URI: http://eprints.soton.ac.uk/id/eprint/337432
ISSN: 0031-6970
PURE UUID: 13fa85dc-eb23-4a57-a5f1-f93d8c5a4ade

Catalogue record

Date deposited: 26 Apr 2012 08:53
Last modified: 14 Mar 2024 10:53

Export record

Altmetrics

Contributors

Author: Barbro Dahlén
Author: Federico P. Gómez
Author: Alejandro Casas
Author: Sven-Erik Dahlén
Author: Robert Rodriguez-Roisin

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×